Connection

Kwok-Yung Yuen to Administration, Oral

Back to Details
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Administration, Oral.
Kwok-Yung Yuen
Connection Strength
0.218
Administration, Oral
  1. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy. Antiviral Res. 2018 12; 160:38-47.
    View in: PubMed
    Score: 0.109
  2. An oral mucosal DNA vaccine for SARS coronavirus infections. Hong Kong Med J. 2009 Feb; 15 Suppl 2:41-2.
    View in: PubMed
    Score: 0.056
  3. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
    View in: PubMed
    Score: 0.044
  4. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24; 361(9371):1767-72.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.